Kallisio partners with Stanford Health Care on rollout of Stentra system for head-and-neck radiation therapy

Five-treatment radiation regimen poised to become standard of care, phase III data show

Men with intermediate-risk prostate cancer can receive a complete course of radiation in just five treatments—rather than the typical 20 to 28—while maintaining excellent cancer control and improving quality of life, according to results of an international phase III trial conducted by Rodney J. Ellis.

October 10, 2025

Vol.51 No.37

In Brief

Joseph Contessa appointed chair of radiation oncology at Rutgers Cancer Institute

Joseph Contessa was named chair of radiation oncology for Rutgers Cancer Institute, Rutgers Robert Wood Johnson Medical School, and Rutgers New Jersey Medical School. He will also serve as associate director for translational research at Rutgers Cancer Institute.

August 08, 2025

Vol.51 No.31

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya

In a move that will have direct impact on approval of cancer drugs, George Francis Tidmarsh, an oncologist and a longtime pharmaceutical executive, was named director of the FDA Center for Drug Evaluation and Research.

July 25, 2025

Vol.51 No.29

By Claire Marie Porter

In Brief

Weill Cancer Hub West secures $200M to support launch of UCSF-Stanford collaboration

A $100 million matching grant from the Weill Family Foundation is supporting the launch of the Weill Cancer Hub West—a collaboration between the UCSF Helen Diller Family Comprehensive Cancer Center and the Stanford Cancer Institute—set up to accelerate discoveries and speed the development of innovative new treatments for patients.

July 25, 2025

Vol.51 No.29

In Brief

Karen Davis named vice president of business development and marketing at ASTRO

The American Society for Radiation Oncology recently welcomed Karen Davis as its first vice president of business development and marketing.

June 20, 2025

Vol.51 No.24

In the Archives

Melvin J. Silverstein reflects on 25 years of controversy surrounding DCIS and radiation

Silverstein during his surgical oncology fellowship, c. 1972This month on the Cancer History Project Podcast, Melvin J. Silverstein, Medical Director of Hoag Breast Center and the Gross Family Foundation Endowed Chair in Oncoplastic Breast Surgery at USC, sat down with Stacy Wentworth, radiation oncologist and medical historian, to reflect on his career—and founding the first free-standing breast center.

June 06, 2025

Vol.51 No.22

Kallisio partners with Stanford Health Care on rollout of Stentra system for head-and-neck radiation therapy

YOU MAY BE INTERESTED IN

Five-treatment radiation regimen poised to become standard of care, phase III data show

Joseph Contessa appointed chair of radiation oncology at Rutgers Cancer Institute

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya

Weill Cancer Hub West secures $200M to support launch of UCSF-Stanford collaboration

Karen Davis named vice president of business development and marketing at ASTRO

Melvin J. Silverstein reflects on 25 years of controversy surrounding DCIS and radiation

Renew today!

Subscriber content

Never miss an issue!

Login

Kallisio partners with Stanford Health Care on rollout of Stentra system for head-and-neck radiation therapy

YOU MAY BE INTERESTED IN

Five-treatment radiation regimen poised to become standard of care, phase III data show

Joseph Contessa appointed chair of radiation oncology at Rutgers Cancer Institute

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER directorHis appointment came out of “proximity” to Makary and Bhattacharya

Weill Cancer Hub West secures $200M to support launch of UCSF-Stanford collaboration

Karen Davis named vice president of business development and marketing at ASTRO

Melvin J. Silverstein reflects on 25 years of controversy surrounding DCIS and radiation

Never miss an issue!

Login

Oncologist biotech entrepreneur George Tidmarsh joins FDA as CDER director
His appointment came out of “proximity” to Makary and Bhattacharya